This book examines how government, industry and society interact to reach a level of regulation that is deemed satisfactory for the newly-emerged transformative technology that is agricultural biotechnology. It considers issues of risk and trust surrounding genetically-modified plants for the production of food and pharmaceuticals. It describes how regulations have been produced to manage, or in some cases ignore, the risks from GM products. The scope is international and the book makes a significant contribution to the literature in this growing field of interest.